India

Indian lender Ujjivan Financial Services and healthcare firm Thyrocare Technologies have filed draft prospectuses for IPOs with the country’s capital markets regulator.

Société Générale is shuttering its equity research offering in India and has relocated its team from Mumbai to Bangalore in the process.

Indian pharmaceutical companies Cipla and Lupin are set to tap the syndicated loan market in 2016 to refinance bridge loans they raised for acquisitions in early 2015.

A $1.5bn refinancing for Tata Steel that went into senior syndication in early December has been funded by 17 lenders.

Narayana Hrudayalaya has continued the stellar run of healthcare-themed IPOs in India with its Rp6.13bn ($92m) listing, which priced on Wednesday at the top of the indicative range.

Indian pharmaceutical company Strides Shasun Arcolabs has priced a qualified institutional placement — which raised Rp11.03bn ($166.4m) — below its floor price, according to a filing with India’s National Stock Exchange on Monday.

The Securities and Exchange Board of India has put together a consultation paper for the public issuance of units of infrastructure investment trusts (InvITs), tackling topics ranging from filing an offer document to divvying up stock to potential investors.

Tata Chemicals Europe's £140m ($216m) five year dual-tranche facility has received commitments from two banks and is set to wind up in January.

A $305m three year borrowing for Tata Power's subsidiary, Khopoli Investments, has received commitments from two banks, having been in general syndication since September.

Aditya Birla Group company UltraTech Cement has wound up a $365m dual-tranche refinancing with five lenders in the syndicate.

India's Azure Power Global is seeking approval to float on the New York Stock Exchange, having a filed a preliminary prospectus with the Securities and Exchange Commission on Wednesday.

A $200m equivalent borrowing for Yue Xiu Enterprises has been launched into syndication with one bank at the helm.